Immunotherapy
Immunotherapy
Immunotherapy is a type of cancer treatment that helps your immune system recognize and attack cancer cells. Unlike chemotherapy, which directly kills cancer cells, immunotherapy uses substances made by the body or in a laboratory to bolster or restore immune system function. It is considered a revolutionary turning point in oncology, moving the needle for cancers that were once considered difficult to treat by training the body's natural defenses to fight back.
When You Should Consider Immunotherapy
High PD-L1 Expression: When testing shows your tumor uses the PD-L1 protein to "hide" from immune cells; drugs can block this signal.
High Tumor Mutational Burden (TMB): Cancers with many genetic changes (like those caused by smoking or UV damage) are often easier for the immune system to "see" as a threat.
Frontline Treatment: For many advanced lung cancers and melanomas, immunotherapy is now the first choice before traditional chemotherapy.
Durable Response Seekers: For patients looking for "long-term remission," as the immune system can sometimes "remember" the cancer and keep fighting it even after treatment stops.
MSI-High Status: If your cancer has a specific genetic feature called "Microsatellite Instability-High," making it highly sensitive to immune-based drugs.
How It Works (The Mechanisms)
Checkpoint Inhibitors: These block the "off-switches" (like PD-1 or CTLA-4) on immune cells. By keeping the switches "on," the immune system stays active enough to kill the cancer.
Monoclonal Antibodies: Lab-made proteins that "mark" cancer cells so the immune system can find them, or block specific proteins that help tumors grow.
T-cell Transfer Therapy (CAR-T): Your own immune cells are removed, "reprogrammed" in a lab to find your specific cancer, and re-infused as "super-soldiers."
Cancer Vaccines: Unlike preventive vaccines, these are given to people who already have cancer to help the body recognize and destroy existing tumor cells.
Dual-Targeting (2026 Standard): Newer "bispecific" antibodies that attach to a cancer cell and an immune cell simultaneously, physically pulling the killer cell toward its target.
How Immunotherapy Is Administered
IV Infusion: Most drugs (like Keytruda or Opdivo) are given via a vein in an outpatient clinic.
Cycle-Based Schedule: Administered in cycles, typically once every 2, 3, 4, or 6 weeks, depending on the specific drug and your body's response.
Long-Term Duration: Treatment can continue for up to two years if the cancer remains stable and you do not experience severe side effects.
Home Monitoring: Because side effects can be delayed, you may be asked to use a digital health app to track symptoms like cough or diarrhea daily.
Combination Protocols: Frequently given alongside low-dose chemo or targeted therapy to "prime" the tumor for an immune attack.
Pre-Procedure Preparation
Biomarker Testing: You must undergo PD-L1 or NGS testing to confirm that immunotherapy is the right biological match for your cancer.
Baseline Organ Function: Thorough checks of your thyroid, liver, and lungs are essential, as these are the organs most likely to be affected by an overactive immune system.
Infection Screening: Doctors will screen for latent infections (like Hepatitis B or C) that could be reactivated when the immune system is "revved up."
Steroid Review: High doses of steroids (like prednisone) can sometimes make immunotherapy less effective, so your medications will be reviewed.
Patient Education: It is vital to learn the "early warning signs" of immune-related side effects, which are very different from chemotherapy side effects.
Tests During Immunotherapy
Response Assessment (The "Wait"): Scans are done every 2 to 3 months. Note: You may experience "Pseudo-progression," where a tumor looks larger at first because it is full of fighting immune cells.
Endocrine Panels: Monthly blood tests to check thyroid (TSH) and adrenal function, as the immune system can sometimes accidentally attack these glands.
Liquid Biopsy (2026 Standard): Monitoring "circulating tumor DNA" in the blood to see if the treatment is working before it shows up on a traditional CT scan.
Liver Enzymes: Regular checks for immune-mediated hepatitis (inflammation of the liver).
Lung Monitoring: Checking for pneumonitis (lung inflammation) via physical exams and, if needed, chest X-rays or CT scans.
Life During Immunotherapy
The "Healthy" Appearance: Many patients do not lose their hair or experience severe nausea, allowing them to continue working and exercising during treatment.
Reporting irAEs: You must report even minor "new" symptoms immediately. A simple rash or a slight cough can escalate quickly if the immune system is over-attacking.
The "Steroid Pivot": If you develop significant inflammation, you may need to pause treatment and take high-dose steroids to "calm" the immune system down.
Sun Protection: Some immunotherapies make your skin extra sensitive; use high-SPF sunscreen and protective clothing.
Long-Term Vigilance: Side effects can occasionally appear months or even a year after you finish treatment, so stay in touch with your oncology team.
Benefits of Immunotherapy
Potential for "Cure": In certain cancers, immunotherapy has led to long-term survival that was previously impossible with chemotherapy alone.
Less Collateral Damage: By targeting the immune system rather than killing all fast-growing cells, many patients maintain a much higher quality of life.
Broad Application: Some immunotherapy drugs are "tumor-agnostic," meaning they can treat many different types of cancer as long as the genetic marker is present.
Memory Effect: The immune system's ability to "remember" cancer cells provides a built-in defense system against future recurrence.
2026 Precision: Advances in AI and molecular profiling now allow doctors to predict with 80% accuracy who will respond to these life-saving drugs.